InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations

InStride Health, a leading insurance-based provider of specialty anxiety and obsessive-compulsive disorder (OCD) treatment for children, adolescents and young adults, today announced three changes to ...
E-Commerce Times

Retailers Should Prepare for GenAI-Driven Shoppers, BCG Warns

GenAI tools have become practical shopping aids, guiding consumers at critical decision points and helping them make faster, ...
Le Lézard

BostonGene and Sylvester Comprehensive Cancer Center to Showcase Omnimodal AI Clinical Trial Innovations at Association for Molecular Pathology 2025 Annual Meeting & Expo

BostonGene, developer of the leading AI foundation model for cancer and the immune system, today announced that it will showcase its latest advances at the Association for Molecular Pathology (AMP) ...
TMCnet

ORYZON Announces Positive Clinical Data of Iadademstat at ASH-2025

Updated preliminary data from the ongoing Phase Ib FRIDA trial evaluating iadademstat in combination with gilteritinib in FLT3-mutated relapsed/refractory AML showed a 67% response rate in the ...